Results 91 to 100 of about 31,188 (302)

Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to investigate the association between migraine frequency and insomnia severity. Background Migraine and insomnia frequently co‐occur, yet the relationship between migraine characteristics and insomnia severity remains poorly understood.
Kuang‐Heng Lee, Chih‐Sung Liang, Po‐Kuan Yeh, Chia‐Kuang Tsai, Chia‐Lin Tsai, Yu‐Kai Lin, Guan‐Yu Lin, Ming‐Chen Tsai, Yi Liu, Yuan‐Zhen Ruan, Fu‐Chi Yang   +10 more
wiley   +1 more source

A hypothetical proposal for association between migraine and Meniere's disease. [PDF]

, 2020
Meniere's disease (MD) is a chronic condition affecting the inner ear whose precise etiology is currently unknown. We propose the hypothesis that MD is a migraine-related phenomenon which may have implications for future treatment options for both ...
Abouzari, Mehdi, Djalilian, Hamid R, Lin, Harrison W, Sarna, Brooke   +3 more
core  

Migraine aura without headache compared to migraine with aura in patients with affective disorders [PDF]

The Journal of Headache and Pain, 2005
The characteristics of psychiatric comorbidity in migraine have been studied in migraine with aura (MA) and migraine without aura (MO). Little information is available concerning patients with migraine aura without headache. In a study of 201 patients with major affective disorders (DSM-IV) we have described the clinical characteristics of patients ...
Oedegaard, K. J., Angst, J., Neckelmann, D., Fasmer, O. B.   +3 more
openaire   +2 more sources

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza, Víctor Obach, Daniel Guisado‐Alonso, Fernando Velasco Juanes, Rocío Álvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Aintzine Ruisánchez, Natalia Roncero, Ane Mínguez‐Olaondo, Amaya Echeverria, Alba López‐Bravo, Ángel Luis Guerrero‐Peral, David García‐Azorín, Elisa Cuadrado‐Godia, Galca‐Only Study Group, Neus Fabregat, Marta Ruibal, Izaro Kortazar Zubizarreta, Nuria Riesco, Lucia González‐Fernández, Paula Manera, Agustín Oterino Duran, Yésica González‐Osorio, Santiago Fernández‐Fernández, Juan Carlos García‐Moncó, Isabel Fernández‐Pérez, Joan Jiménez‐Balado   +27 more
wiley   +1 more source

Letter to the Editor: Frequency of Visual Aura in Non-Migraine Headache Strongly Depends on the Underlying Pathophysiology [PDF]

, 2023
Josef Finsterer
openalex   +1 more source

Headache in a patient with Klinefelter's syndrome and hyperostosis frontalis interna. [PDF]

, 2007
Hyperostosis frontalis interna (HFI) has been reported in older women, but reports in men are rare. We present a novel case of migraine headache in a gentleman with Klinefelter's syndrome and HFI, along with a discussion of possible pathophysiologic ...
Liebeskind, David S, Ramchandren, Sindhu, Ramchandren, Sindhu   +2 more
core   +2 more sources

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To evaluate the effect of erenumab treatment beyond monthly migraine days in patients with high‐frequency episodic migraine who did not respond to at least one previous migraine preventive treatment. Background Reduction in monthly migraine days has been the efficacy standard for migraine preventive treatments; however, it does not ...
Gabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó, Sebastian Szklener, Cristina Tassorelli, Marcin Nastaj, Denise E. Chou, Ani C. Khodavirdi, Mahan Chehrenama, Yineng Zhu, Ajay K. Bhatia, David W. Dodick   +11 more
wiley   +1 more source

Causal association between systemic lupus erythematosus and the risk of migraine: A Mendelian randomization study

Brain and Behavior
Background Numerous studies have found that patients with systemic lupus erythematosus (SLE) often have comorbid headache, especially migraine. However, the causal relationship between genetically determined SLE and migraine risk remains unclear ...
Meixuan Ren, Hangtian Yu, Bing Xiao, Yan Zhao, Jiewei Yan, Jianghong Liu   +5 more
doaj   +1 more source

Alice in wonderland syndrome. a clinical and pathophysiological review [PDF]

, 2016
Alice in Wonderland Syndrome (AIWS) is a perceptual disorder, principally involving visual and somesthetic integration, firstly reported by Todd, on the literary suggestion of the strange experiences described by Lewis Carroll in Alice in Wonderland ...
DI PIERO, Vittorio, Mancini, Valentina, Mastria, Giulio, Vigano', Alessandro   +3 more
core   +3 more sources

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani, Larry Charleston IV, Shannon Strom, Detlef Albrecht, Robert Cowan   +4 more
wiley   +1 more source